Reuters -- Savient Pharmaceuticals Inc said it plans to cut 26 jobs, or about 38 percent of its workforce, to reduce costs and focus on the resubmission of marketing application for its experimental gout drug.
Reuters -- Savient Pharmaceuticals Inc said it plans to cut 26 jobs, or about 38 percent of its workforce, to reduce costs and focus on the resubmission of marketing application for its experimental gout drug.
